| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to value-based arrangements for prescription drugs in |
|
|
Medicaid. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Section 531, Government Code, is amended by |
|
|
adding Section 531.0701 to read as follows: |
|
|
|
|
|
Sec. 531.0701. VALUE-BASED ARRANGEMENTS. Subject to |
|
|
531.071, the commission may enter into a written agreement with a |
|
|
manufacturer of prescription drugs as defined by 42 U.S.C. Section |
|
|
1396r-8(k)(5) and its subsequent amendments, including a |
|
|
subsidiary or affiliate of a manufacturer, based on outcomes data, |
|
|
or other metrics agreed to in writing by the state and a |
|
|
pharmaceutical manufacturer. Such agreements may include but not |
|
|
be limited to rebates, discounts, price reductions, contributions, |
|
|
risk sharing, reimbursements, deferral of payments (e.g. |
|
|
installment payments), guarantees, patient care, shared savings |
|
|
payments, withholds, or bonuses or anything of value. |
|
|
SECTION 2. The Health and Human Services Commission shall |
|
|
amend contracts with managed care plans to ensure those contracts |
|
|
comply with Section 531.0701, Government Code, as added by this |
|
|
Act. |
|
|
SECTION 3. This Act takes effect September 1, 2019. |